Journal of Clinical Medicine Research, ISSN 1918-3003 print, 1918-3011 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Clin Med Res and Elmer Press Inc
Journal website http://www.jocmr.org

Original Article

Volume 9, Number 1, January 2017, pages 30-34


Hyaluronic Acid Fat Graft Myringoplasty Versus Autologous Platelet Rich Plasma

Figures

Figure 1.
Figure 1. After centrifugation blood was separated into three layers: the bottom layer consists of red blood cells, the middle layer contains platelet poor plasma (PRP), which is composed of platelets and white blood cells (WBCs), and the top layer contains platelet poor plasma (PPP).
Figure 2.
Figure 2. Right ear operated with PRPM technique shows postero-superiorly retracted healed tympanic membrane at 6 months postoperatively with external auditory canal pearl of cholesteatoma (arrow).
Figure 3.
Figure 3. Right ear operated with HAFGM technique shows the healed tympanic membrane at 12 months postoperatively. We can identify the corda tympani through the new ear drum.

Tables

Table 1. Demographic Data
 
PatientsHAFGM (N = 16)PRP (N = 11)P value
HAFGM: hyaluronic acid fat graft myringoplasty; PRPM: platelet rich plasma myringoplasty.
Gender0.97
  Male74
  Female97
Age (years)55.8570.88
Side0.67
  Right43
  Left126
Previous surgery240.54
Results< 0.001
  Success132
  Failure39
Postoperative complications03 (1 myringitis, 2 cholesteatoma )0.02

 

Table 2. Success Rates According to the Size of Tympanic Membrane Perforation
 
Grade of perforationPatients
ResultHAFGM (n = 16)PRP (n = 9)P value
HAFGM: hyaluronic acid fat graft myringoplasty; PRPM: platelet rich plasma myringoplasty; NA: not applicable.
I (< 25%)Success710.0002
Failure05
II (25-50%)Success30NA
Failure12
III (50-75%)Success20NA
Failure11
IV (≥ 75%)Success11NA

 

Table 3. Audiometric Results
 
PTA = 500 + 1,000 + 2,000 + 3,000 + 4,000/4 dB HLPre-operatively6 months postoperatively12 months postoperativelyP value
6 months12 months
PTA: pure tone average; BC: bone conduction; SDS: speech discrimination score; SD: standard deviation; NA: not applicable.
HAFGMPTA44.32830.3< 0.0001< 0.0001
BC24.42220.40.2430.23
SDS %94.694.2950.7170.068
PRPPTA4741.4130 (N = 3)0.93N/A
BC3031.1828.60.94N/A
SDS %86.984.890.60.386N/A

 

Table 4. Review Studies Show the Success Rates of HAFGM
 
Review studiesNo. of patientsSexAgeSuccess rate
F: female; M: male.
Saliba, 2008 [4]21F = 13, M = 853.6 years81%
Saliba and Froehlich, 2011 [5]73F = 30, M = 4311.62 years87%
Saliba and Woods, 2011 [7]131F = 86, M = 4548 years92.70%
Saliba et al, 2012 [6]50F = 15, M = 3511.68 years90%
Alzahrani and Saliba, 2015 [15]10F = 4, M = 649 years80%
Gun et al, 2016 [16]31F = 16, M = 1525 years87.10%